The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: -2.50 (-4.31%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 55.50
Low: 55.50
Prev. Close: 58.00
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a supplementary prospectus

7 Dec 2021 16:04

RNS Number : 8782U
Baronsmead Second Venture Trust PLC
07 December 2021
 

 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

 

Baronsmead Second Venture Trust plc

 

LEI: 213800VQ1PQHOJXDDQ88

 

7 December 2021

 

Publication of a supplementary prospectus

Baronsmead Second Venture Trust plc (the "Company") has today published a supplementary prospectus approved by the Financial Conduct Authority (the "Supplementary Prospectus"). The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules following the publication of the Company's annual report and audited financial statements for the financial year ended 30 September 2021.

The Supplementary Prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company and Baronsmead Venture Trust plc on 4 November 2021 in respect of offers for subscription to raise up to £50 million in aggregate together with an over-allotment facility to raise up to a further £25 million in aggregate.

A copy of the Supplementary Prospectus will shortly be available for inspection at the National Storage Mechanism which is located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Supplementary Prospectus is also available in electronic form on the Company's website at www.baronsmeadvcts.co.uk.

 

For further information please contact:

 

Baronsmead VCT Investor Relations

020 7382 0999 baronsmeadvcts@greshamhouse.com

 

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 4 November 2021 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc in connection with the proposed admission of new ordinary shares to the premium segment of the Official List of the FCA and to trading on London Stock Exchange plc's main market for listed securities. A copy of the Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus. Potential investors are recommended to read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

The distribution of this Announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This Announcement does not constitute, and may not be construed as, an offer to sell, or the solicitation of an offer to acquire or subscribe for, securities of the Companies in any jurisdiction where such offer or solicitation is unlawful or would impose any unfulfilled registration, qualification, publication or approval requirements on the Companies or Dickson Minto W.S. The offer and sale of securities of the Companies has not been and will not be registered under the applicable securities laws of Australia, Canada, Japan, the Republic of South Africa or the United States. Subject to certain exemptions, the securities of the Companies may not be offered to or sold within Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA or to any national, resident or citizen of Australia, Canada, Japan, the Republic of South Africa, the United States, or any member state of the EEA.

This Announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This Announcement is not an offer of securities for sale into the United States. The securities of the Companies have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to any national, resident or citizen of the United States. No public offering of securities is being made in the United States. In addition, neither of the Companies have been and neither will be registered under the US Investment Company Act of 1940, as amended.

The information in this Announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this Announcement or its accuracy or completeness. This Announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any securities of the Companies or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor. The material contained in this Announcement is given as at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment.

This Announcement does not constitute a recommendation concerning the Companies or the Offers. The price and value of securities and any income from them can go down as well as up. Past performance is not a guide to future performance and prospective investors may not receive any return from the Companies. Before purchasing any securities of the Companies, persons viewing this Announcement should ensure that they fully understand and accept the risks set out in the Prospectus. Information in this Announcement or any of the documents relating to the Companies or the Offers cannot be relied upon as a guide to future performance. Potential investors should consult a professional adviser as to the suitability of the Offers for them.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPDKOBKABDDDBK
Date   Source Headline
15th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20223:15 pmRNSNet Asset Value(s)
27th May 20227:00 amRNSHalf-year Report
6th May 20223:15 pmRNSNet Asset Value(s)
3rd May 20225:12 pmRNSTotal Voting Rights
25th Apr 20225:28 pmRNSTransaction in Own Shares
19th Apr 20226:20 pmRNSDirector Declaration
14th Apr 20223:00 pmRNSNet Asset Value(s)
1st Apr 20227:00 amRNSTotal Voting Rights
15th Mar 20224:30 pmRNSIssue of Ordinary Shares
15th Mar 202211:05 amRNSDirector/PDMR Shareholding
11th Mar 20223:00 pmRNSNet Asset Value(s)
9th Mar 20227:00 amRNSTransaction in Own Shares - Correction
8th Mar 20223:53 pmRNSTransaction in Own Shares
7th Mar 20223:31 pmRNSPublication of a Prospectus
3rd Mar 20221:30 pmRNSNet Asset Value(s)
1st Mar 202211:47 amRNSTotal Voting Rights
28th Feb 20224:51 pmRNSOffer for Subscription - Update
16th Feb 20224:51 pmRNSResult of AGM
4th Feb 20225:45 pmRNSNet Asset Value(s)
3rd Feb 20224:57 pmRNSTotal Voting Rights
1st Feb 20222:53 pmRNSTotal Voting Rights
28th Jan 202211:58 amRNSAllotment of Shares
27th Jan 20223:30 pmRNSNet Asset Value(s)
26th Jan 20224:59 pmRNSTransaction in Own Shares
21st Jan 20222:00 pmRNSNet Asset Value(s)
4th Jan 20221:34 pmRNSTotal Voting Rights
22nd Dec 20214:51 pmRNSAllotment of Shares
20th Dec 20216:18 pmRNSTransaction in Own Shares
20th Dec 202112:37 pmRNSUpdate on Fundraising
8th Dec 20215:08 pmRNSCorrection: Annual Financial Report
8th Dec 202112:19 pmRNSDirector/PDMR Shareholding
8th Dec 202111:54 amRNSDirector/PDMR Shareholding
8th Dec 202111:53 amRNSDirector/PDMR Shareholding
8th Dec 202111:52 amRNSDirector/PDMR Shareholding
7th Dec 20214:04 pmRNSPublication of a supplementary prospectus
6th Dec 20215:20 pmRNSAllotment of Shares
6th Dec 202112:24 pmRNSAnnual Financial Report
3rd Dec 20214:00 pmRNSNet Asset Value(s)
10th Nov 20218:00 amRNSOffer Update - Extension of Earlybird Rebate
8th Nov 20215:45 pmRNSNet Asset Value(s)
4th Nov 20211:00 pmRNSPublication of a Prospectus
28th Oct 20213:00 pmRNSReplacement Net Asset Value(s)
21st Oct 20211:00 pmRNSNet Asset Value(s)
1st Oct 202111:36 amRNSTotal Voting Rights
29th Sep 20216:28 pmRNSTransaction in Own Shares
14th Sep 202111:29 amRNSSale of shares from Treasury
14th Sep 20219:36 amRNSUpdate on Offer for Subscription
7th Sep 20219:31 amRNSNet Asset Value(s)
5th Aug 20214:08 pmRNSIntention to Launch an Offer for Subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.